Pharma

I have been noticing Teva and Mylan getting sued a lot for patent infringement. I am not clear if it is because I am reading the financial news more often or the trend for generics is over.

But I do know that it is clearly a time for mergers and acquisitions in the pharma industry. And probably a good time to buy some.

They pay on average, 5% dividend. What's there to hate?

My list is 1) AMGN 2) MATK (at book value) 3) KG 4) BIIB 5) SNY (some news on diversification in food products) 6) BMY (buy out candidate though nothing has happened)